Knockout of lncRNA UCA1 inhibits drug resistance to gefitinib via targeting STAT3 signaling in NSCLC

Minerva Med. 2019 Jun;110(3):273-275. doi: 10.23736/S0026-4806.19.05979-2. Epub 2019 Feb 14.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Carcinoma, Non-Small-Cell Lung / genetics*
  • Drug Resistance, Neoplasm / genetics*
  • Gefitinib / therapeutic use*
  • Gene Knockout Techniques*
  • Humans
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / genetics*
  • RNA, Long Noncoding / genetics*
  • STAT3 Transcription Factor / genetics*
  • Signal Transduction

Substances

  • Antineoplastic Agents
  • RNA, Long Noncoding
  • STAT3 Transcription Factor
  • STAT3 protein, human
  • UCA1 RNA, human
  • Gefitinib